LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to fix dangerous blood problems caused by cancer immunotherapy
Disease control Not yet recruitingThis study tests a drug called golidocitinib in 16 people with advanced lung cancer who have severe, hard-to-treat blood problems caused by immunotherapy. The goal is to see if the drug can safely reverse these blood side effects. Participants must not have had cancer growth in t…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
New immune drug targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new drug, CRPA1A2, that helps the immune system attack cancer cells. It is for people with certain advanced solid tumors (like lung, esophagus, head and neck, or liver cancer) who have a specific genetic marker (HLA-A*02:01 and MAGE-A1). The main go…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Corregene Biotechnology Co., Ltd • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Can your own immune cells fight advanced cancer? new study aims to find out
Disease control Not yet recruitingThis early-phase study is testing a new treatment for people with advanced lung, liver, colorectal, or breast cancer. The therapy uses a patient's own immune cells, which are collected, trained in a lab to better recognize and attack cancer, and then infused back into the body. T…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
Lung cancer staging may get more accurate with simple needle flush
Knowledge-focused Not yet recruitingThis study looks at whether cleaning the needle used in a lung biopsy more thoroughly can prevent leftover cancer cells from contaminating samples. About 204 adults with suspected lung cancer will take part. The goal is to see if a simple extra rinse helps doctors stage the cance…
Matched conditions: LUNG CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: University of Mississippi Medical Center • Aim: Knowledge-focused
Last updated May 12, 2026 13:44 UTC